Lord, Abbett & Co. LLC Veracyte, Inc. Transaction History

Lord, Abbett & Co. LLC

$28.1 Billion
Q1 2025

A detailed history of Lord, Abbett & Co. LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 234,692 shares of VCYT stock, worth $6.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

234,692

Previous 389,606 39.76%

Holding current value

$6.46 Million

Previous $15.4 Million 54.89%

% of portfolio

0.02%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$29.65 - $46.14 $4.59 Million - $7.15 Million	-154,914 Reduced 39.76%	234,692 $6.96 Million
Q4 2024 Feb 14, 2025	BUY	$31.92 - $44.4 $3.53 Million - $4.91 Million	110,574 Added 39.63%	389,606 $15.4 Million
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $5.86 Million - $9.84 Million	279,032 New	279,032 $9.5 Million
Q2 2021 Aug 11, 2021	SELL	$32.94 - $56.62 $6 Million - $10.3 Million	-182,284 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$44.47 - $81.38 $3.05 Million - $5.57 Million	-68,492 Reduced 27.31%	182,284 $9.8 Million
Q4 2020 Feb 09, 2021	BUY	$32.49 - $61.88 $2.13 Million - $4.06 Million	65,608 Added 35.43%	250,776 $12.3 Million
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $830,126 - $1.11 Million	31,056 Added 20.15%	185,168 $6.02 Million
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $1.6 Million - $2.31 Million	-82,180 Reduced 34.78%	154,112 $3.99 Million
Q1 2020 May 14, 2020	SELL	$16.13 - $30.17 $3.35 Million - $6.27 Million	-207,738 Reduced 46.78%	236,292 $5.74 Million
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $5.99 Million - $8.64 Million	288,188 Added 184.92%	444,030 $12.4 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $3.72 Million - $4.82 Million	155,842 New	155,842 $3.74 Million

Others Institutions Holding VCYT

# of Institutions

306

Shares Held

79.1M

Call Options Held

15.5K

Put Options Held

16.7K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Veracyte, Inc. Transaction History